We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
featured

Journal Scan / Research · December 03, 2020

Increased Overall Survival in Patients With MBC and Liver or Lung Metastases Treated With Eribulin

Breast Cancer Research and Treatment

 

Additional Info

Breast Cancer Research and Treatment
Overall Survival Analysis in Patients With Metastatic Breast Cancer and Liver or Lung Metastases Treated With Eribulin, Gemcitabine, or Capecitabine
Breast Cancer Res Treat 2020 Nov 01;184(2)559-565, S Kazmi, D Chatterjee, D Raju, R Hauser, PA Kaufman

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading